Information provided by Healthline.com

Lyme disease - early disseminated  Health Article

Licensed from Print
Table of Contents
Reviewer Info: Kenneth M. Wener, M.D., Department of Infectious Diseases, Lahey Clinic, Burlington, MA. Review provided by VeriMed Healthcare Network.; ADAM Health Illustrated Encyclopedia, 11/01/2007

Definition

Early disseminated or secondary Lyme disease is an inflammatory disease caused by the bacterium Borrelia burgdorferi.

See also:

Alternative Names

Lyme disease - secondary or stage 2; Stage 2 Lyme disease

Causes, incidence, and risk factors

Lyme disease is transmitted through the bite of an infected tick. Secondary Lyme disease develops within days to months after the tick bite, when the infection spreads via the lymph system or bloodstream.

Symptoms

Lyme disease can affect the central nervous system and cardiac system. Symptoms can come and go and may disappear after days, weeks, or months.

Symptoms include:

Other symptoms that can occur with this disease:

Signs and tests

A physical examination may show signs of neurological problems or heart involvement.

Tests that may be done include:

  • Chest x-ray
  • ECG
  • ELISA test to screen for substances specific to the infection
  • Examination of cerebrospinal (CSF) fluid
  • Western blot to confirm the presence of antibodies to Borrelia burgdorferi

Treatment

The objective of treatment is to get rid of the infection with antibiotics. Antibiotics given through a vein (intravenous) are sometimes needed to cure the infection.

Expectations (prognosis)

Symptoms of arthritis may not respond to treatment. Other symptoms should improve with treatment.

Complications

Calling your health care provider

Call your health care provider if you develop symptoms of this disorder.

Prevention

Getting diagnosed early and treating Lyme disease with antibiotics are the most effective ways to prevent secondary Lyme disease.

References

Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Disease Society of America. Clin Infect Dis. November 2006;43:1089-1134.

advertisement

Back to Top Print

Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.